Wada Hideo, Ichikawa Yuhuko, Ezaki Minoru, Shiraki Katsuya, Moritani Isao, Yamashita Yoshiki, Matsumoto Takeshi, Masuya Masahiro, Tawara Isao, Shimpo Hideto, Shimaoka Motomu
Department of Laboratory and General Medicine, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.
Department of Central Laboratory, Mie Prefectural General Medical Center, Yokkaichi 510-8561, Japan.
J Clin Med. 2021 Dec 20;10(24):5987. doi: 10.3390/jcm10245987.
Although platelets, which contain large amounts of phospholipids, play an important role in blood coagulation, there is still no routine assay to examine the effects of platelets in blood coagulation.
Hemostatic abnormalities in patients with thrombocytopenia, including those with idiopathic thrombocytopenic purpura (ITP), were examined using clot wave analysis (CWA)-small-amount tissue-factor-induced FIX activation (sTF/FIXa) and thrombin time (TT).
Although there were no marked differences in the three parameters of activated partial thromboplastin time (APTT) between normal healthy volunteers and typical patients with ITP, the peak heights of the CWA-sTF/FIXa were markedly low in patients with ITP. The three peak times of the CWA-sTF/FIXa in patients with a platelet count of ≤8.0 × 10/L were significantly longer than those in patients with a platelet count > 8.0 × 10/L and the peak heights of the CWA-sTF/FIXa in patients with a platelet count of ≤8.0 × 10/L were significantly lower than those in patients with >8.0 × 10/L. The peak heights of the CWA-APTT in patients with ITP were significantly lower than in patients with other types of thrombocytopenia. The three peak heights of the CWA-sTF/FIXa in ITP patients were significantly lower than those in patients with other types of thrombocytopenia. The CWA-TT showed lower peak heights and longer peak times in patients with ITP in comparison to patients with other types of thrombocytopenia.
The CWA-sTF/FIXa and CWA-TT results showed that blood coagulation is enhanced by platelets and that the blood coagulation ability in ITP patients was low in comparison to healthy volunteers and patients with other types of thrombocytopenia.
尽管含有大量磷脂的血小板在血液凝固中起重要作用,但目前仍没有常规检测方法来检查血小板在血液凝固中的作用。
使用凝血波分析(CWA)-小剂量组织因子诱导的FIX激活(sTF/FIXa)和凝血酶时间(TT)检测血小板减少症患者(包括特发性血小板减少性紫癜(ITP)患者)的止血异常情况。
正常健康志愿者与典型ITP患者之间活化部分凝血活酶时间(APTT)的三个参数无明显差异,但ITP患者CWA-sTF/FIXa的峰值明显较低。血小板计数≤8.0×10/L的患者CWA-sTF/FIXa的三个峰值时间明显长于血小板计数>8.0×10/L的患者,且血小板计数≤8.0×10/L的患者CWA-sTF/FIXa的峰值明显低于>8.0×10/L的患者。ITP患者CWA-APTT的峰值明显低于其他类型血小板减少症患者。ITP患者CWA-sTF/FIXa的三个峰值明显低于其他类型血小板减少症患者。与其他类型血小板减少症患者相比,ITP患者的CWA-TT峰值较低且峰值时间较长。
CWA-sTF/FIXa和CWA-TT结果表明血小板可增强血液凝固,且与健康志愿者及其他类型血小板减少症患者相比,ITP患者的血液凝固能力较低。